Individualized molecular cancer therapy based on radiolabelled somatostatin analogues | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.09.2008 | Review article

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

verfasst von: M. Gabriel, U. Andergassen, I. J. Virgolini

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Treatment options in localised and metastatic renal cell carcinoma

Nächster Artikel Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

Titel: Individualized molecular cancer therapy based on radiolabelled somatostatin analogues
verfasst von: M. Gabriel
U. Andergassen
I. J. Virgolini
Publikationsdatum: 01.09.2008
Verlag: Springer-Verlag
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2008
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-008-0056-8

Weitere Artikel der Ausgabe 3/2008

Proteomics, a new tool to monitor cancer therapy?

Review

Approaching personalized cancer medicine

Commentary

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

Case report

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

Review

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

Short review

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

Short review